AACR Policy Documents, Letters & Position Statements

 

AACR Position Statements 

 

• Tobacco and Cancer: An American Association for Cancer Research Policy Statement (April 13, 2010)

• AACR Statement on Proposed Medicare Coverage of Erythropoiesis Stimulating Agents (ESAs) (June 13, 2007)

• Responsible Exploration of the Full Spectrum of Stem Cell Biology is Essential to the Advancement of Cancer Research (2005) 

• AACR Comments on the NIH Interim Ethics Rule (2005)

• Precancers: Opening a New Front in the War on Cancer (2002)

• Statement on Smoking and Lung Cancer (1984) 

 

AACR Policy Documents

• Comments to FDA Regarding Enrichment Strategies for Clinical Trials (March 12, 2013)

• Comments to ONC HIT Policy Committee regarding proposed Meaningful Use Stage 3 Criteria (January 14, 2013)

• Comments regarding the Patient-Centered Outcomes Research Institute’s draft Methodology Report (September 14, 2012)

• Comments to FDA regarding Pathologic Complete Response as a surrogate end point in neoadjuvant studies (July 30, 2012)

• Comments to CMS regarding draft Stage 2 Meaningful Use criteria (May 7, 2012)

• Comments regarding the Patient-Centered Outcomes Research Institute’s draft National Priorities and Research Agenda (March 15, 2012) 

• Comments to CMS in response to updated guidance on the Coverage with Evidence Development (CED) policy (Jan. 20, 2012)

• Cancer coalition recommendations to CMS on clinical trials coverage regulations (Jan. 18, 2012)

• AACR, ASCO, AACI comments in response to HHS Advance Notice of Proposed Rulemaking (ANPRM), “Human Subjects Research Protections: Enhancing Protections for Research Subjects and Reducing Burden, Delay and Ambiguity for Investigators” (Oct. 26, 2011)

• Comments to FDA in response to the December 2010 draft guidance, “Codevelopment of Two or More Unmarketed Investigational Drugs for Use in Combination” (Feb. 14, 2011)

• Comments to the FDA Regarding Cigarette Labeling (Jan. 11, 2011)

• Comments to the FDA Regarding the Co-development of Investigational Drugs (Sept. 7, 2010)

• AACR Comments to the FDA Regarding the Implementation of the Family Smoking Prevention and Tobacco Control Act (Sept. 29, 2009)

AACR Letters

 

FY2013 Cancer Research Funding:

• Letter to House Members Regarding FY2013 Programmatic Requests (Feb. 29, 2012)

• Cancer Research Community Letter to Congress Regarding FY2013 Funding (May 31, 2012)

 

FY2012 Cancer Research Funding:

• Letter to Joint Special Committee on Deficit Reduction (Oct. 19, 2011)

• Letter to House Appropriators Regarding FY2012 Funding (July 20, 2011)

• Letter to Members of Congress Regarding FY2011 and FY2012 Funding (Feb. 6, 2011)

FY2011 Cancer Research Funding:

• Letter to Members of the Senate Urging Opposition to McCaskill-Sessions Amendment to Impose Statutory Caps on Domestic Discretionary Funding through FY2013 (March 11, 2010)
  

• Letter to Senate Budget Committee Regarding FY2011 Budget Resolution (Feb. 16, 2010)

• Letter to House Budget Committee Regarding FY2011 Budget Resolution (Feb. 16, 2010)

• Letter to President Obama Regarding FY2011 Budget Proposal (Jan. 29, 2010)

 

FY2010 Cancer Research Funding: 

• Letter to Senate Appropriations Committee Regarding FY2010 Budget (July 27, 2009)

• Letter to House Appropriations Committee Regarding FY2010 Budget (July 27, 2009)

 

FY2009 Cancer Research Funding:

• Letter to Senate Appropriations Committee Regarding FY2009 Budget (June 18, 2008)

• Letter to House Appropriations Committee Regarding FY2009 Budget (June 18, 2008)

• Letter to House Leadership Regarding Supplemental Spending Bill (Aug. 28, 2008)

 

Other Cancer Policy Issues:

• AACR Urges Senate not to Exempt Cigars from FDA Regulation (April 25, 2013)

• AACR Urges House not to Exempt Cigars from FDA Regulation (April 24, 2013)

• Letter of Support for Senator Obama’s Cancer Plan (Sept. 8, 2009)

• Thank You Letter to President Obama Regarding Stem Cell Executive Order (March 23, 2009)

• Letter in Support of Michigan’s Ballot Initiative Regarding Embryonic Stem Cell Research (Oct. 15, 2008)

• Letter to Sen. Jack Reed Supporting the Conquer Childhood Cancer Act (S.911) (Nov. 6, 2007)